Group 107 Ltd. (IL:G107)
TASE:G107
Top Page
Group 107
(TASE:G107)
Select Model
Select Model
Rating:40Underperform
Price Target:
96.00
▼(-23.93% Downside)
Action:DowngradedDate:01/20/26
The score is driven primarily by weak financial performance: ongoing unprofitability, negative operating cash flow, and high leverage outweigh moderate revenue growth and improving free cash flow growth. Technicals also pressure the score as the stock trades below all major moving averages with negative MACD, despite oversold readings (RSI/Stoch). Valuation provides limited support because the company is loss-making (negative P/E) and dividend yield is not available.
Positive Factors
Sustained Revenue Growth
Consistent revenue growth indicates ongoing demand for the company’s products and supports longer-term scale. Over a multi-quarter horizon, steady top-line expansion can enable reinvestment in R&D and sales, improving market position if managed alongside margin pressures.
Negative Factors
Persistent Unprofitability
Ongoing negative net profit and EBIT margins indicate the business has not yet achieved operating profitability. Over a multi-quarter horizon this limits retained earnings, constrains reinvestment capacity, and increases reliance on external financing to sustain operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Consistent revenue growth indicates ongoing demand for the company’s products and supports longer-term scale. Over a multi-quarter horizon, steady top-line expansion can enable reinvestment in R&D and sales, improving market position if managed alongside margin pressures.
Read all positive factors
Group 107 (G107) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪24.85M
Dividend YieldN/A
Average Volume (3M)60.21K
Price to Earnings (P/E)149.3
Beta (1Y)0.17
Revenue Growth26.93%
EPS Growth71.40%
CountryIL
Employees221
SectorServices
Sector StrengthN/A
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)-0.80
Shares Outstanding29,342,375
10 Day Avg. Volume39,586
30 Day Avg. Volume60,213
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)23.23
Price to Sales (P/S)0.35
P/FCF Ratio-22.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Group 107 Business Overview & Revenue Model
Company Description
Group 107 Ltd. provides software solutions and services in Israel. The company offers Levent, a cloud-based solution designed to work as an algo-trading system for banks, hedge funds, and brokers; and Borsa Live, a real time stocks tracking app. I...
How the Company Makes Money
G107 generates revenue through multiple streams, primarily from the sale of its software applications and medical devices, which are marketed to both businesses and consumers. The company also earns income from long-term contracts with healthcare ...
Group 107 Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
30
Negative
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.46M | 33.81M | 30.36M | 29.20M | 16.18M | 7.11M |
| Gross Profit | 11.72M | 8.84M | 6.44M | 5.20M | 4.45M | 2.51M |
| EBITDA | 386.00K | -148.00K | -2.94M | -6.75M | -10.88M | -1.62M |
| Net Income | -588.00K | -1.33M | -3.88M | -8.12M | -10.22M | -802.00K |
Balance Sheet | ||||||
| Total Assets | 11.30M | 11.32M | 4.07M | 6.71M | 12.94M | 621.00K |
| Cash, Cash Equivalents and Short-Term Investments | 912.00K | 1.77M | 1.02M | 1.85M | 10.56M | 92.00K |
| Total Debt | 2.24M | 1.82M | 1.31M | 1.58M | 1.14M | 2.27M |
| Total Liabilities | 9.01M | 9.04M | 5.26M | 5.53M | 3.74M | 4.19M |
| Stockholders Equity | 819.00K | 509.00K | -1.20M | 1.18M | 9.20M | -3.57M |
Cash Flow | ||||||
| Free Cash Flow | -1.34M | -525.00K | -1.74M | -7.73M | -9.17M | -614.00K |
| Operating Cash Flow | -1.10M | -436.00K | -1.71M | -7.30M | -7.75M | -385.00K |
| Investing Cash Flow | -4.00K | 842.00K | 53.00K | -504.00K | -1.65M | -229.00K |
| Financing Cash Flow | -869.00K | 335.00K | 939.00K | -918.00K | 19.64M | 721.00K |
Group 107 Technical Analysis
Positive
126.20
Price Trends
111.23
Positive
Market Momentum
2.87
Positive
56.50
Neutral
52.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:G107, the sentiment is Positive. The current price of 126.2 is above the 20-day moving average (MA) of 117.25, above the 50-day MA of 111.23, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 2.87 indicates Positive momentum. The RSI at 56.50 is Neutral, neither overbought nor oversold. The STOCH value of 52.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:G107.
Group 107 Peers Comparison
UnderperformOutperform
Sector (55)
IL:G107
Group 107
84.70
35.20
71.11%
IL:MRHL
Merchavia Hold
180.30
97.30
117.23%
IL:AILN
Axilion
38.80
9.10
30.64%
IL:AMDA
Almeda Pu
201.50
33.30
19.80%
IL:SHMM
Shamaym
193.80
56.50
41.15%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.